文献速递肿瘤 PET/CT

新诊断前列腺癌患者初始长期雄激素剥夺治疗前后[68Ga]Ga-PSMA-11 PET的回顾性研究

[68Ga]Ga-PSMA-11 PET before and after initial long-term androgen deprivation in patients with newly diagnosed prostate cancer: a retrospective single-center study.
PubMed 文献 · EJNMMI Res · 2020-11-06

该单中心回顾性研究纳入21例初治寡转移前列腺癌患者,在雄激素剥夺治疗(ADT)前后行[68Ga]Ga-PSMA-11 PET/CT或PET/MRI,比较SUVmax、SUVmean、PSMA-TV、TL-PSMA及miPSMA评分等定性与定量参数。ADT中位155天后,所有患者PSA下降(中位29.1降至0.71,p<0.001),病灶数量及PSMA表达降低,11例(52.7%)出现miN和/或miM降期,各PET参数与T2时PSA仅中度相关。

要点

  • ADT后PSMA阳性病灶数及表达降低,残留PSA<1 ng/ml者更明显。
  • 11例(52.7%)出现miN和/或miM降期。
  • 各PET参数间强相关,与T2时PSA仅中度相关。

核心结论

  • ADT后扫描显示PSMA阳性病灶减少且PSMA表达整体降低,尤其在残留PSA<1 ng/ml的患者中,与原发肿瘤部位或转移部位无关。
  • 各PET参数均与T2时PSA仅中度相关,无参数显示优越性,简单易得的miPSMA评分似乎最适合评估ADT对PSMA表达的影响。

研究设计与样本

  • 单中心回顾性分析21例初治寡转移前列腺癌患者(中位年龄70岁)。
  • 患者在ADT开始前(T1)及ADT期间(T2)行[68Ga]Ga-PSMA-11 PET/CT或PET/MRI。
  • ADT中位持续时间155天(范围61-289天)。

主要发现

  • 两次检查共视觉检出109个PSMA阳性病灶(24个前列腺内、56个淋巴结、29个骨),T2时1例患者检出2个新骨病灶。
  • ADT期间所有患者PSA下降(中位29.1降至0.71,p<0.001)。
  • 长期ADT期间病灶数量明显减少,尤其T2时PSA<1 ng/ml者(中位4降至0.9,p=0.007),PSMA表达降低,11例(52.7%)出现miN和/或miM降期。
  • 所有分析的PET参数之间强相关,T2时PSA水平与PSMA表达下降及其衍生体积仅中度相关。

临床怎么用

  • 解读ADT后PSMA PET时需考虑PSMA表达降低及病灶减少,避免低估肿瘤负荷。
  • 对残留PSA<1 ng/ml者,ADT后PSMA PET病灶减少更明显。
  • miPSMA评分简单易得,可用于评估ADT对PSMA表达的影响。

局限性

  • 回顾性单中心设计,样本量21例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The study aimed to evaluate the effect of androgen deprivation therapy (ADT) on PSMA imaging and its correlation to the PSA concentration by comparing qualitative and quantitative parameters: SUVmax, SUVmean, PSMA-derived tumor volume (PSMA-TV), total lesion PSMA (TL-PSMA) and molecular imaging (mi)PSMA score. METHODS: Retrospective analysis of 21 therapy-naïve patients with oligometastatic prostate cancer (median age 70 years) who underwent either [68Ga]Ga-PSMA-11-PET/CT or -PET/MRI before initiation of (T1) as well as during ADT (T2). The median duration of ADT was 155 days (range 61-289 days). All lesions were analyzed using several qualitative and quantitative PET parameters. RESULTS: A total of 109 PSMA-positive lesions (24 intraprostatic, 56 lymphonodal and 29 osseous) were visually detected at any of the examinations, while at T2, two new bone lesions were detected in one patient. During ADT, all patients experienced a decrease in their PSA level (median: 29.1 before vs. 0.71 after; p < 0.001). During long-term ADT, a relevant decrease in lesion count occurred, especially in patients with a T2 PSA value < 1 ng/ml (median: 4 vs. 0.9; p = 0.007) and PSMA expression, which resulted in miN- and/or miM-downstaging in 11 patients (52.7%). All analyzed PET parameters correlated strongly with each other. The PSA level at T2 correlated modestly with the decrease in PSMA expression and its derived volumes. CONCLUSION: Post-ADT scans detected, especially in patients with a residual PSA < 1 ng/ml, fewer PSMA-positive lesions with overall lower PSMA expression, regardless of primary tumor site or metastatic sites. None of the PET parameters has proven to be superior, as they all correlated modestly with the PSA value at T2. Thus, the simply acquirable miPSMA score seems to be the most suitable for evaluating the effect of ADT on PSMA expression.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Hoberück S, Löck S, Winzer R, et al. [68Ga]Ga-PSMA-11 PET before and after initial long-term androgen deprivation in patients with newly diagnosed prostate cancer: a retrospective single-center study. EJNMMI Res. 2020. PMID: 33159278. doi:10.1186/s13550-020-00723-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。